Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT

A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation

Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742 · see citing works

Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases

DEYO, R. (1992) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(92)90133-8 · Cited by 10,452 · see citing works

The Statistical Analysis of Failure Time Data.

Aitkin, M. A., Kalbfleisch, J. D., & Prentice, R. L. (1981) · Biometrics · doi:10.2307/2530581 · Cited by 9,875 · see citing works

Validation of a combined comorbidity index

Charlson, M., Szatrowski, T. P., Peterson, J., & Gold, J. (1994) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(94)90129-5 · Cited by 6,587 · see citing works

International scoring system for evaluating prognosis in myelodysplastic syndromes

Greenberg, P., Cox, C., LeBeau, M. M., Fenaux, P., Morel, P., Sanz, G., Sanz, M., Vallespi, T., Hamblin, T., Oscier, D., et al. (1997) · Blood · doi:10.1182/blood.v89.6.2079 · Cited by 4,427 · see citing works

Regression modelling strategies for improved prognostic prediction

Harrell, F. E., Lee, K. L., Califf, R. M., Pryor, D. B., & Rosati, R. A. (1984) · Statistics in Medicine · doi:10.1002/sim.4780030207 · Cited by 1,804 · see citing works

Presentation adapting a clinical comorbidity index for use with ICD-9-CM administrative data: Differing perspectives

Romano, P. S., Roos, L. L., & Jollis, J. G. (1993) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(93)90103-8 · Cited by 1,717 · see citing works

The pre-therapeutic classification of co-morbidity in chronic disease

Feinstein, A. R. (1970) · Journal of Chronic Diseases · doi:10.1016/0021-9681(70)90054-8 · Cited by 1,544 · see citing works

Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for Leukemia

Storb, R. F., Deeg, H. J., Whitehead, J., Appelbaum, F. R., Beatty, P. G., Bensinger, W., Buckner, C. D., Clift, R. A., Doney, K., Farewell, V. T., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198603203141201 · Cited by 1,411 · see citing works

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

McSweeney, P. A., Niederwieser, D. W., Shizuru, J. A., Sandmaier, B. M., Molina, A. J., Maloney, D. G., Chauncey, T. R., Gooley, T. A., Hegenbart, U., Nash, R. A., et al. (2001) · Blood · doi:10.1182/blood.v97.11.3390 · Cited by 1,386 · see citing works

Prognostic Importance of Comorbidity in a Hospital-Based Cancer Registry

Piccirillo, J. F. (2004) · JAMA · doi:10.1001/jama.291.20.2441 · Cited by 1,204 · see citing works

Can Comorbidity Be Measured By Questionnaire Rather than Medical Record Review?

Katz, J. N., Chang, L. C., SANGHA, O., Fossel, A. H., & Bates, D. W. (1996) · Medical Care · doi:10.1097/00005650-199601000-00006 · Cited by 1,035 · see citing works

Comorbidity and functional status are independent in older cancer patients.

Extermann, M., Overcash, J. A., Lyman, G. H., Parr, J., & Balducci, L. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.4.1582 · Cited by 986 · see citing works

Chronic graft-versus-host disease and other late complications of bone marrow transplantation.

Sullivan, K. M., Agura, E. D., Anasetti, C., Appelbaum, F. R., Badger, C. C., Bearman, S. I., Erickson, K., Flowers, M. E. D., Hansen, J. A., & Loughran, T. P. (1991) · PubMed · Cited by 790 · see citing works

The importance of classifying initial co-morbidity in evaluating the outcome of diabetes mellitus

Kaplan, M. H., & Feinstein, A. R. (1974) · Journal of Chronic Diseases · doi:10.1016/0021-9681(74)90017-4 · Cited by 668 · see citing works

Hematopoietic Cell Transplantation

Forman, S. J., & Nakamura, R. (2015) · Medical Entomology and Zoology · Cited by 658 · see citing works

Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation

Gratwohl, A. A., Hermans, J., Goldman, J. M., Arcese, W., Carreras, E., Devergié, A., Frassoni, F., Gahrton, G., Kolb, H., Niederwieser, D. W., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(98)03030-x · Cited by 646 · see citing works

Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation: a randomized double-blind study

Boeckh, M., Gooley, T. A., Myerson, D., Cunningham, T., Schoch, G. H., & Bowden, R. (1996) · Blood · doi:10.1182/blood.v88.10.4063.bloodjournal88104063 · Cited by 643 · see citing works

Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-related death in allogeneic marrow transplant recipients: long-term follow-up of a randomized, placebo-controlled trial

Marr, K. A., Seidel, K. D., Slavin, M. A., Bowden, R. A., Schoch, H. G., Flowers, M. E. D., Corey, L., & Boeckh, M. (2000) · Blood · doi:10.1182/blood.v96.6.2055 · Cited by 510 · see citing works

Adapting the charlson comorbidity index for use in patients with ESRD

Hemmelgarn, B. R., Manns, B., Quan, H., & Ghali, W. A. (2003) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(03)00415-3 · Cited by 496 · see citing works

Charlson Index Comorbidity Adjustment for Ischemic Stroke Outcome Studies

Goldstein, L. B., Samsa, G. P., Matchar, D. B., & Horner, R. D. (2004) · Stroke · doi:10.1161/01.str.0000135225.80898.1c · Cited by 483 · see citing works

Measuring comorbidity in older cancer patients

Extermann, M. (2000) · European Journal of Cancer · doi:10.1016/s0959-8049(99)00319-6 · Cited by 477 · see citing works

Comorbidity and age as predictors of risk for early mortality of male and female colon carcinoma patients: a population-based study.

Yancik, R., Wesley, M. N., Ries, L., Havlik, R. J., Long, S., Edwards, B. K., & Yates, J. W. (1998) · PubMed · Cited by 408 · see citing works

Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myeloma

Maloney, D. G., Molina, A. J., Sahebi, F., Stockerl-Goldstein, K. E., Sandmaier, B. M., Bensinger, W., Storer, B. E., Hegenbart, U., Somlo, G., Chauncey, T. R., et al. (2003) · Blood · doi:10.1182/blood-2002-09-2955 · Cited by 403 · see citing works

Marrow transplantation for chronic myeloid leukemia: a randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide

Ra, C., Buckner, C. D., Thomas, E. D., Singer, J. W., Bowden, R. A., Bryant, E. M., Deeg, H. J., Doney, K., Fisher, L. D., & Hansen, J. (1994) · Blood · doi:10.1182/blood.v84.6.2036.2036 · Cited by 357 · see citing works

Clinical Approach to Infection in the Compromised Host

(1995) · Springer eBooks · doi:10.1007/978-1-4615-6642-7 · Cited by 337 · see citing works

HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies

Maris, M. B., Niederwieser, D. W., Sandmaier, B. M., Storer, B. E., Stuart, M. J., Maloney, D. G., Petersdorf, E. W., McSweeney, P. A., Pulsipher, M. A., Woolfrey, A. E., et al. (2003) · Blood · doi:10.1182/blood-2003-02-0482 · Cited by 334 · see citing works

Graft-Versus-Tumor Effects After Allogeneic Hematopoietic Cell Transplantation With Nonmyeloablative Conditioning

Baron, F., Maris, M. B., Sandmaier, B. M., Storer, B. E., Sorror, M. L., Diaconescu, R., Woolfrey, A. E., Chauncey, T. R., Flowers, M. E. D., Mielcarek, M. B., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.08.136 · Cited by 332 · see citing works

Long-term survivors in metastatic non-small-cell lung cancer: an Eastern Cooperative Oncology Group Study.

Finkelstein, D. M., Ettinger, D. S., & Ruckdeschel, J. C. (1986) · Journal of Clinical Oncology · doi:10.1200/jco.1986.4.5.702 · Cited by 325 · see citing works

Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donors

Diaconescu, R., Flowers, C. R., Storer, B. E., Sorror, M. L., Maris, M. B., Maloney, D. G., Sandmaier, B. M., & Storb, R. F. (2004) · Blood · doi:10.1182/blood-2004-03-0804 · Cited by 321 · see citing works

Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: influence of pretransplantation comorbidities

Sorror, M. L., Maris, M. B., Storer, B. E., Sandmaier, B. M., Diaconescu, R., Flowers, C. R., Maloney, D. G., & Storb, R. F. (2004) · Blood · doi:10.1182/blood-2004-02-0545 · Cited by 320 · see citing works

Measurement and impact of comorbidity in older cancer patients

Extermann, M. (2000) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(00)00090-1 · Cited by 300 · see citing works

Perspectives on Comorbidity and Cancer in Older Patients: Approaches to Expand the Knowledge Base

Yancik, R., Ganz, P. A., Varricchio, C. G., & Conley, B. A. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.4.1147 · Cited by 283 · see citing works

Conditioning with targeted busulfan and cyclophosphamide for hemopoietic stem cell transplantation from related and unrelated donors in patients with myelodysplastic syndrome

Deeg, H. J., Storer, B. E., Slattery, J. T., Anasetti, C., Doney, K., Hansen, J. A., Kiem, H., Martin, P. J., Petersdorf, E. W., Radich, J. P., et al. (2002) · Blood · doi:10.1182/blood-2002-02-0527 · Cited by 283 · see citing works

Comorbid Illness is Associated with Survival and Length of Hospital Stay in Patients with Chronic Disability

Rochon, P. A., Katz, J. N., MORROW, L. A., McGlinchey, R. E., Ahlquist, M. M., Sarkarati, M., & Minaker, K. L. (1996) · Medical Care · doi:10.1097/00005650-199611000-00004 · Cited by 269 · see citing works

Allogeneic hematopoietic cell transplantation after fludarabine and 2 Gy total body irradiation for relapsed and refractory mantle cell lymphoma

Maris, M. B., Sandmaier, B. M., Storer, B. E., Chauncey, T. R., Stuart, M. J., Maziarz, R. T., Agura, E. D., Langston, A. A., Pulsipher, M. A., Storb, R. F., et al. (2004) · Blood · doi:10.1182/blood-2004-06-2275 · Cited by 255 · see citing works

Validation of the Charlson Comorbidity Index in Patients With Head and Neck Cancer: A Multi‐institutional Study

Singh, B., Bhaya, M. H., Stern, J., Roland, J. T., Zimbler, M. S., Rosenfeld, R. M., Har‐El, G., & Lucente, F. E. (1997) · The Laryngoscope · doi:10.1097/00005537-199711000-00009 · Cited by 251 · see citing works

Graft-Versus-Host Disease

Professor, H.-W. V. (2006) · Springer eBooks · doi:10.1007/3-540-27806-0_623 · Cited by 242 · see citing works

Hematopoietic Cell Transplantation After Nonmyeloablative Conditioning for Advanced Chronic Lymphocytic Leukemia

Sorror, M. L., Maris, M. B., Sandmaier, B. M., Storer, B. E., Stuart, M. J., Hegenbart, U., Agura, E. D., Chauncey, T. R., Leis, J. F., Pulsipher, M. A., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.569 · Cited by 230 · see citing works

Association of depressive syndrome and early deaths among patients after stem-cell transplantation for malignant diseases.

Loberiza, F., Rizzo, J. D., Bredeson, C., Antin, J., Horowitz, M. M., Weeks, J. C., & Lee, S. J. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.08.757 · Cited by 225 · see citing works

The prognostic importance of comorbidity for mortality in patients with stable coronary artery disease

Sachdev, M., Sun, J. L., Tsiatis, A. A., Nelson, C. L., Mark, D. B., & Jollis, J. G. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.10.031 · Cited by 204 · see citing works

Comorbidity and Karnofksy performance score are independent prognostic factors in stage III non-small-cell lung cancer: an institutional analysis of patients treated on four RTOG studies

Firat, S. Y., Byhardt, R. W., & Gore, E. (2002) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(02)02939-5 · Cited by 197 · see citing works

Successful Modification of a pp65 Antigenemia-Based Early Treatment Strategy for Prevention of Cytomegalovirus Disease in Allogeneic Marrow Transplant Recipients

Boeckh, M., Bowden, R. A., Gooley, T. A., Myerson, D., & Corey, L. (1999) · Blood · doi:10.1182/blood.v93.5.1781.405a39c_1781_1782 · Cited by 162 · see citing works

Hepatic injury after nonmyeloablative conditioning followed by allogeneic hematopoietic cell transplantation: a study of 193 patients

Hogan, W. J., Maris, M. B., Storer, B. E., Sandmaier, B. M., Maloney, D. G., Schoch, H. G., Woolfrey, A. E., Shulman, H. M., Storb, R. F., & McDonald, G. B. (2003) · Blood · doi:10.1182/blood-2003-04-1311 · Cited by 156 · see citing works

Subdiaphragmatic and intrathoracic paraspinal malignant peripheral nerve sheath tumors

Kourea, H. P., Bilsky, M. H., Leung, D. H. Y., Lewis, J. J., & Woodruff, J. M. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980601)82:11 · Cited by 149 · see citing works

Comorbidity measurement in elderly female breast cancer patients with administrative and medical records data

Newschaffer, C. J., Bush, T. L., & Penberthy, L. (1997) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(97)00050-4 · Cited by 148 · see citing works

Factors influencing outcome in de novo myelodysplastic syndromes treated by allogeneic bone marrow transplantation: a long-term study of 71 patients Societe Francaise de Greffe de Moelle

Sutton, L., Chastang, C., Ribaud, P., Jouet, J. P., Kuentz, M., Attal, M., Reiffers, J. J., Tigaud, J., Rio, B., Dauriac, C., et al. (1996) · Blood · doi:10.1182/blood.v88.1.358.358 · Cited by 140 · see citing works

Charlson Comorbidity Index is a Predictor of Outcomes in Incident Hemodialysis Patients and Correlates with Phase Angle and Hospitalization

Iorio, B. R. D., Cillo, N., Círillo, M., & Santo, N. G. D. (2004) · The International Journal of Artificial Organs · doi:10.1177/039139880402700409 · Cited by 123 · see citing works

Long-term low-dose acyclovir against varicella-zoster virus reactivation after allogeneic hematopoietic stem cell transplantation

Kanda, Y., Mineishi, S., Saito, T., Saito, A. M., Yamada, S., Ohnishi, M., Chizuka, A., Niiya, H., Suenaga, K., Nakai, K., et al. (2001) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1703214 · Cited by 107 · see citing works

Severe cardiac toxicity in hematological stem cell transplantation: predictive value of reduced left ventricular ejection fraction

Fujimaki, K., Maruta, A., Yoshida, M., Sakai, R., Tanabe, J., Koharazawa, H., Kodama, F., Asahina, S., Minamizawa, M., Matsuzaki, M., et al. (2001) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1702783 · Cited by 95 · see citing works

Non‐myeloablative allografting from human leucocyte antigen‐identical sibling donors for treatment of acute myeloid leukaemia in first complete remission

Feinstein, L. C., Sandmaier, B. M., Hegenbart, U., McSweeney, P. A., Maloney, D. G., Gooley, T. A., Maris, M. B., Chauncey, T. R., Bruno, B., Appelbaum, F. R., et al. (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04057.x · Cited by 93 · see citing works

Allogeneic bone marrow transplantation for acute leukemia in patients over the age of 40 years

Cahn, J.-Y. Y., Labopin, M., Schattenberg, A. V. M. B., Reiffers, J. J., Willemze, R., Zittoun, R., Bacigalupo, A. P., Prentice, G., Gluckman, É., Hervé, P., et al. (1997) · Leukemia · doi:10.1038/sj.leu.2400573 · Cited by 62 · see citing works

The Impact of Comorbidity and Age on Survival with Laryngeal Cancer

Sabin, S. L., Rosenfeld, R. M., Sundaram, K., Har‐El, G., & Lucente, F. E. (1999) · Ear Nose & Throat Journal · doi:10.1177/014556139907800813 · Cited by 57 · see citing works

Predictors of Mortality in Outpatient Geriatric Evaluation and Management Clinic Patients

Keller, B. K., & POTTER, J. F. (1994) · Journal of Gerontology · doi:10.1093/geronj/49.6.m246 · Cited by 53 · see citing works

Prognostic relevance of ‘early‐onset’ graft‐versus‐host disease following non‐myeloablative haematopoietic cell transplantation

Mielcarek, M. B., Burroughs, L. M., Leisenring, W. M., Diaconescu, R., Martin, P. J., Sandmaier, B. M., Maloney, D. G., Maris, M. B., Chauncey, T. R., Shizuru, J. A., et al. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05458.x · Cited by 41 · see citing works

Allogeneic marrow transplantation following cyclophosphamide and escalating doses of hyperfractionated total body irradiation in patients with advanced lymphoid malignancies: A Phase I/II trial

Demirer, T., Petersen, F. B., Appelbaum, F. R., Barnett, T., Sanders, J. E., Deeg, H. J., Storb, R. F., Doney, K., Bensinger, W., Shannon‐Dorcy, K., et al. (1995) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(95)00115-f · Cited by 40 · see citing works

Elderly age and prior autologous transplantation have a deleterious effect on survival following allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning: results from the Spanish multicenter prospective trial

Gómez‐Núñez, M., Martino, R., Caballero, M. D., Pérez‐Simón, J. A., Canals, C., Mateos, M., Sarrà, J., León, A., Solano, C., Moraleda, J. M., et al. (2004) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1704379 · Cited by 39 · see citing works

Infection in Hematopoietic Stem Cell Transplantation

Boeckh, M., & Marr, K. A. (2002) · Springer eBooks · doi:10.1007/0-306-47527-8_16 · Cited by 34 · see citing works

Korreliert der Charlson-Comorbidity-Index mit dem postoperativen Verlauf bei Patienten mit Magenkarzinom?

Lübke, T., Mönig, S., Schneider, P. M., Hölscher, A., & Bollschweiler, E. (2003) · Zentralblatt für Chirurgie - Zeitschrift für Allgemeine Viszeral- Thorax- und Gefäßchirurgie · doi:10.1055/s-2003-44805 · Cited by 25 · see citing works

Handbook of Bone Marrow Transplantation

Carella, A. M., Lazarus, H. M., & Rowe, J. M. (2000) · Medical Entomology and Zoology · Cited by 21 · see citing works

Prognostic Relevance of “Early-Onset” Graft-Versus-Host Disease Following Nonmyeloablative Hematopoietic Cell Transplantation.

Mielcarek, M. B., Burroughs, L. M., Leisenring, W. M., Martin, P. J., Diaconezcu, R., Sandmaier, B. M., Maloney, D. G., Chauncey, T. R., Maris, M. B., Shizuru, J. A., et al. (2004) · Blood · doi:10.1182/blood.v104.11.423.423 · Cited by 9 · see citing works

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

Döhner, H., Estey, E. H., Amadori, S., Appelbaum, F. R., Büchner, T., Burnett, A. K., Dombret, H., Fenaux, P., Grimwade, D. J., Larson, R. A., et al. (2009) · Blood · doi:10.1182/blood-2009-07-235358 · Cited by 3,348 · see citing works

Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN

Döhner, H., Wei, A. H., Appelbaum, F. R., Craddock, C., Dinardo, C. D., Dombret, H., Ebert, B. L., Fenaux, P., Godley, L. A., Hasserjian, R. P., et al. (2022) · Blood · doi:10.1182/blood.2022016867 · Cited by 3,430 · see citing works

2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)

Lyon, A. R., López‐Fernández, T., Couch, L. S., Asteggiano, R., Aznar, M. C., Bergler-Klein, J. K., Boriani, G., Cardinale, D. M., Córdoba, R., Cosyns, B., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac244 · Cited by 3,301 · see citing works

Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation

Gooley, T. A., Chien, J. W., Pergam, S. A., Hingorani, S. R., Sorror, M. L., Boeckh, M., Martin, P. J., Sandmaier, B. M., Marr, K. A., Appelbaum, F. R., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1004383 · Cited by 1,491 · see citing works

Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation

Armand, P. A., Kim, H. T., Logan, B. R., Wang, Z. P., Alyea, E. P., Kalaycio, M. E., Maziarz, R. T., Antin, J. H., Soiffer, R. J., Weisdorf, D. J., et al. (2014) · Blood · doi:10.1182/blood-2014-01-552984 · Cited by 951 · see citing works

The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation

Taur, Y., Jenq, R. R., Perales, M.-A., Littmann, E. R., Morjaria, S., Ling, L., No, D., Gobourne, A., Viale, A., Dahi, P. B., et al. (2014) · Blood · doi:10.1182/blood-2014-02-554725 · Cited by 885 · see citing works

Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in First Complete Remission

Koreth, J., Schlenk, R. F., Kopecky, K. J., Honda, S., Sierra, J., Djulbegović, B., Wadleigh, M., DeAngelo, D. J., Stone, R. M., Sakamaki, H., et al. (2009) · JAMA · doi:10.1001/jama.2009.813 · Cited by 887 · see citing works

Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation

Peled, J. U., Gomes, A. L. C., Devlin, S. M., Littmann, E. R., Taur, Y., Sung, A. D., Weber, D., Hashimoto, D., Slingerland, A. E., Slingerland, J. B., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1900623 · Cited by 765 · see citing works

Therapeutic Advances in Acute Myeloid Leukemia

Burnett, A. K., Wetzler, M., & Löwenberg, B. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.1820 · Cited by 786 · see citing works

Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Eichhorst, B. F., Robak, T., Montserrat, E., Ghia, P., Niemann, C. U., Kater, A. P., Gregor, M., Cymbalista, F., Buske, C., Hillmen, P., et al. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2020.09.019 · Cited by 585 · see citing works

2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)

Lyon, A. R., López‐Fernández, T., Couch, L. S., Asteggiano, R., Aznar, M. C., Bergler-Klein, J. K., Boriani, G., Cardinale, D. M., Córdoba, R., Cosyns, B., et al. (2022) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jeac106 · Cited by 531 · see citing works

Composite end point of graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic cell transplantation

Holtan, S. G., DeFor, T. E., Lazaryan, A., Bejanyan, N., Arora, M., Brunstein, C. G., Blazar, B. R., MacMillan, M. L., & Weisdorf, D. J. (2015) · Blood · doi:10.1182/blood-2014-10-609032 · Cited by 501 · see citing works

Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease

Brunstein, C. G., Barker, J. N., Weisdorf, D. J., DeFor, T. E., Miller, J. S., Blazar, B. R., McGlave, P. B., & Wagner, J. E. (2007) · Blood · doi:10.1182/blood-2007-04-067215 · Cited by 500 · see citing works

T-Cell–Replete HLA-Haploidentical Hematopoietic Transplantation for Hematologic Malignancies Using Post-Transplantation Cyclophosphamide Results in Outcomes Equivalent to Those of Contemporaneous HLA-Matched Related and Unrelated Donor Transplantation

Bashey, A., Zhang, X., Sizemore, C. A., Manion, K., Brown, S. L., Holland, H. K., Morris, L. E., & Solomon, S. R. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.44.3523 · Cited by 498 · see citing works

The impact of therapy-related acute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnosed AML

Kayser, S., Döhner, K., Krauter, J., Köhne, C.-H., Horst, H. A., Held, G., von Lilienfeld-Toal, M., Wilhelm, S., Kündgen, A., Götze, K., et al. (2011) · Blood · doi:10.1182/blood-2010-08-301713 · Cited by 487 · see citing works

Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Eichhorst, B., Hallek, M., & Dreyling, M. H. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq180 · Cited by 456 · see citing works

Geriatric assessment predicts survival for older adults receiving induction chemotherapy for acute myelogenous leukemia

Klepin, H. D., Geiger, A. M., Tooze, J. A., Kritchevsky, S. B., Williamson, J. D., Pardee, T. S., Ellis, L. R., & Powell, B. L. (2013) · Blood · doi:10.1182/blood-2012-12-471680 · Cited by 427 · see citing works

Comorbidity-Age Index: A Clinical Measure of Biologic Age Before Allogeneic Hematopoietic Cell Transplantation

Sorror, M. L., Storb, R. F., Sandmaier, B. M., Maziarz, R. T., Pulsipher, M. A., Maris, M. B., Bhatia, R., Ostronoff, F., Deeg, H. J., Syrjala, K. L., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.53.8157 · Cited by 424 · see citing works

Cytomegalovirus viral load and mortality after haemopoietic stem cell transplantation in the era of pre-emptive therapy: a retrospective cohort study

Green, M. L., Leisenring, W. M., Xie, H., Mast, T. C., Cui, Y. A., Sandmaier, B. M., Sorror, M. L., Goyal, S., Özkök, S., Yi, J., et al. (2016) · The Lancet Haematology · doi:10.1016/s2352-3026(15)00289-6 · Cited by 420 · see citing works

Impact of Pretransplantation Minimal Residual Disease, As Detected by Multiparametric Flow Cytometry, on Outcome of Myeloablative Hematopoietic Cell Transplantation for Acute Myeloid Leukemia

Walter, R. B., Gooley, T. A., Wood, B. L., Milano, F., Fang, M., Sorror, M. L., Estey, E. H., Salter, A. I., Lansverk, E., Chien, J. W., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.31.8121 · Cited by 405 · see citing works

The European LeukemiaNet AML Working Party consensus statement on allogeneic HSCT for patients with AML in remission: an integrated-risk adapted approach

Cornelissen, J. J., Gratwohl, A. A., Schlenk, R. F., Sierra, J., Bornhäuser, M., Juliusson, G., Ráčil, Z., Rowe, J. M., Russell, N. H., Mohty, M., et al. (2012) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2012.150 · Cited by 400 · see citing works

Comorbidity and Disease Status–Based Risk Stratification of Outcomes Among Patients With Acute Myeloid Leukemia or Myelodysplasia Receiving Allogeneic Hematopoietic Cell Transplantation

Sorror, M. L., Sandmaier, B. M., Storer, B. E., Maris, M. B., Baron, F., Maloney, D. G., Scott, B. L., Deeg, H. J., Appelbaum, F. R., & Storb, R. F. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.7865 · Cited by 397 · see citing works

Effect of Inpatient Palliative Care on Quality of Life 2 Weeks After Hematopoietic Stem Cell Transplantation

El-Jawahri, A. R., LeBlanc, T. W., Vandusen, H. B., Traeger, L. N., Greer, J. A., Pirl, W. F., Jackson, V. A., Telles, J., Rhodes, A., Spitzer, T. R., et al. (2016) · JAMA · doi:10.1001/jama.2016.16786 · Cited by 399 · see citing works

A disease risk index for patients undergoing allogeneic stem cell transplantation

Armand, P. A., Gibson, C. J., Cutler, C. S., Ho, V. T., Koreth, J., Alyea, E. P., Ritz, J., Sorror, M. L., Lee, S. J., Deeg, H. J., et al. (2012) · Blood · doi:10.1182/blood-2012-03-418202 · Cited by 385 · see citing works

Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022

Snowden, J. A., Sánchez‐Ortega, I., Corbacioglu, S., Basak, G. W., Chabannon, C., de la Cámara, R., Dolstra, H., Duarte, R. F., Glaß, B., Greco, R., et al. (2022) · Bone Marrow Transplantation · doi:10.1038/s41409-022-01691-w · Cited by 392 · see citing works

Increased intensity lymphodepletion and adoptive immunotherapy—how far can we go?

Muranski, P. J., Boni, A., Wrzesinski, C., Citrin, D. E., Rosenberg, S. A., Childs, R. W., & Restifo, N. P. (2006) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0666 · Cited by 358 · see citing works

Genetic abnormalities in myelodysplasia and secondary acute myeloid leukemia: impact on outcome of stem cell transplantation

Yoshizato, T., Nannya, Y., Atsuta, Y., Shiozawa, Y., Iijima‐Yamashita, Y., Yoshida, K., Shiraishi, Y., Suzuki, H., Nagata, Y., Sato, Y., et al. (2017) · Blood · doi:10.1182/blood-2016-12-754796 · Cited by 351 · see citing works

Acute Myeloid Leukemia: A Concise Review

Saultz, J. N., & Garzon, R. (2016) · Journal of Clinical Medicine · doi:10.3390/jcm5030033 · Cited by 343 · see citing works

Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015

Sureda, A. M., Bader, P., Cesaro, S., Dreger, P., Duarte, R. F., Dufour, C., Falkenburg, J. H. F., Farge, D., Gennery, A. R., Kröger, N. M., et al. (2015) · Bone Marrow Transplantation · doi:10.1038/bmt.2015.6 · Cited by 337 · see citing works

Hematopoietic cell transplantation–specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: combined FHCRC and MDACC experiences

Sorror, M. L., Giralt, S. A., Sandmaier, B. M., Lima, M. J. G. D., Shahjahan, M., Maloney, D. G., Deeg, H. J., Appelbaum, F. R., Storer, B. E., & Storb, R. F. (2007) · Blood · doi:10.1182/blood-2007-06-096966 · Cited by 326 · see citing works

Selection of unrelated donors and cord blood units for hematopoietic cell transplantation: guidelines from the NMDP/CIBMTR

Dehn, J. G., Spellman, S. R., Hurley, C. K., Shaw, B. E., Barker, J. N., Burns, L. J., Confer, D. L., Eapen, M., Fernández-Viña, M., Hartzman, R. J., et al. (2019) · Blood · doi:10.1182/blood.2019001212 · Cited by 326 · see citing works

Long-term Outcomes Among Older Patients Following Nonmyeloablative Conditioning and Allogeneic Hematopoietic Cell Transplantation for Advanced Hematologic Malignancies

Sorror, M. L., Sandmaier, B. M., Storer, B. E., Franke, G., Laport, G. G., Chauncey, T. R., Agura, E. D., Maziarz, R. T., Langston, A. A., Hari, P., et al. (2011) · JAMA · doi:10.1001/jama.2011.1558 · Cited by 319 · see citing works

How I treat refractory and early relapsed acute myeloid leukemia

Thol, F. R., Schlenk, R. F., Heuser, M., & Ganser, A. (2015) · Blood · doi:10.1182/blood-2014-10-551911 · Cited by 301 · see citing works

Allogeneic stem cell transplantation provides durable disease control in poor-risk chronic lymphocytic leukemia: long-term clinical and MRD results of the German CLL Study Group CLL3X trial

Dreger, P., Döhner, H., Ritgen, M., Böttcher, S., Busch, R. M., Dietrich, S., Bunjes, D. W., Cohen, S., Schubert, J. E. A., Hegenbart, U., et al. (2010) · Blood · doi:10.1182/blood-2010-03-275420 · Cited by 305 · see citing works

Allogeneic Hematopoietic Stem-Cell Transplantation for Patients 50 Years or Older With Myelodysplastic Syndromes or Secondary Acute Myeloid Leukemia

Lim, Z., Brand, R., Martino, R., van Biezen, A., Finke, J., Bacigalupo, A. P., Beelen, D. W., Devergié, A., Alessandrino, E. P., Willemze, R., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.21.8073 · Cited by 299 · see citing works

Measurable residual disease monitoring by NGS before allogeneic hematopoietic cell transplantation in AML

Thol, F. R., Gabdoulline, R. R., Liebich, A., Klement, P., Schiller, J., Kandziora, C., Hambach, L., Stadler, M., Koenecke, C., Flintrop, M., et al. (2018) · Blood · doi:10.1182/blood-2018-02-829911 · Cited by 298 · see citing works

Comorbidity in older adults with cancer

Williams, G. R., MacKenzie, A. R., Magnuson, A. M., Olin, R. L., Chapman, A. E., Mohile, S. G., Allore, H. G., Somerfield, M. R., Targia, V., Extermann, M., et al. (2015) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2015.12.002 · Cited by 298 · see citing works

Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States

Muffly, L. S., Pasquini, M. C., Martens, M. J., Brazauskas, R., Zhu, X., Adekola, K., Aljurf, M. D., Ballen, K. K., Bajel, A. R., Baron, F., et al. (2017) · Blood · doi:10.1182/blood-2017-03-772368 · Cited by 297 · see citing works

Impact of the degree of anemia on the outcome of patients with myelodysplastic syndrome and its integration into the WHO classification-based Prognostic Scoring System (WPSS)

Malcovati, L., Porta, M. G. D., Strupp, C., Ambaglio, I., Kuendgen, A., Nachtkamp, K., Travaglino, E., Invernizzi, R., Pascutto, C., Lazzarino, M., et al. (2011) · Haematologica · doi:10.3324/haematol.2011.044602 · Cited by 282 · see citing works

Individual Prediction of Heart Failure Among Childhood Cancer Survivors

Chow, E. J., Chen, Y., Kremer, L. C. M., Breslow, N. E., Hudson, M. M., Armstrong, G. T., Border, W. L., Feijen, E. A. M., Green, D. M., Meacham, L. R., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.56.1373 · Cited by 281 · see citing works

De novo acute myeloid leukemia: A population‐based study of outcome in the United States based on the Surveillance, Epidemiology, and End Results (SEER) database, 1980 to 2017

Sasaki, K., Ravandi, F., Kadia, T. M., Dinardo, C. D., Short, N. J., Borthakur, G. M., Jabbour, E. J., & Kantarjian, H. M. (2021) · Cancer · doi:10.1002/cncr.33458 · Cited by 280 · see citing works

Five-Year Follow-Up of Patients With Advanced Chronic Lymphocytic Leukemia Treated With Allogeneic Hematopoietic Cell Transplantation After Nonmyeloablative Conditioning

Sorror, M. L., Storer, B. E., Sandmaier, B. M., Maris, M. B., Shizuru, J. A., Maziarz, R. T., Agura, E. D., Chauncey, T. R., Pulsipher, M. A., McSweeney, P. A., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.4757 · Cited by 279 · see citing works

A concise revised Myeloma Comorbidity Index as a valid prognostic instrument in a large cohort of 801 multiple myeloma patients

Engelhardt, M. M., Domm, A.-S., Dold, S. M., Ihorst, G., Reinhardt, H., Zober, A., Hieke, S., Baayen, C., Müller, S. J., Einsele, H., et al. (2017) · Haematologica · doi:10.3324/haematol.2016.162693 · Cited by 275 · see citing works

Comparison of Outcomes of HLA-Matched Related, Unrelated, or HLA-Haploidentical Related Hematopoietic Cell Transplantation following Nonmyeloablative Conditioning for Relapsed or Refractory Hodgkin Lymphoma

Burroughs, L. M., O’Donnell, P. V., Sandmaier, B. M., Storer, B. E., Luznik, L., Symons, H. J., Jones, R. J., Ambinder, R. F., Maris, M. B., Blume, K. G., et al. (2008) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2008.08.014 · Cited by 265 · see citing works

Hematopoietic cell transplantation‐comorbidity index and Karnofsky performance status are independent predictors of morbidity and mortality after allogeneic nonmyeloablative hematopoietic cell transplantation

Sorror, M. L., Storer, B. E., Sandmaier, B. M., Maloney, D. G., Chauncey, T. R., Langston, A. A., Maziarz, R. T., Pulsipher, M. A., McSweeney, P. A., & Storb, R. F. (2008) · Cancer · doi:10.1002/cncr.23375 · Cited by 264 · see citing works

Geriatric assessment to predict survival in older allogeneic hematopoietic cell transplantation recipients

Muffly, L. S., Kocherginsky, M., Stock, W., Chu, Q., Bishop, M. R., Godley, L. A., Kline, J. P., Liu, H., Odenike, O. M., Larson, R. A., et al. (2014) · Haematologica · doi:10.3324/haematol.2014.103655 · Cited by 255 · see citing works

Blockade of Lymphocyte Chemotaxis in Visceral Graft-versus-Host Disease

Reshef, R., Luger, S. M., Hexner, E. O., Loren, A. W., Frey, N. V., Nasta, S. D., Goldstein, S. C., Stadtmauer, E. A., Smith, J., Bailey, S. L., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1201248 · Cited by 254 · see citing works

The haematopoietic cell transplantation comorbidity index score is predictive of early death and survival in patients over 60 years of age receiving induction therapy for acute myeloid leukaemia.

Giles, F. J., Borthakur, G. M., Ravandi, F., Faderl, S. H., Verstovšek, S., Thomas, D. A., Wierda, W. G., Ferrajoli, A., Kornblau, S. M., Pierce, S. A., et al. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06476.x · Cited by 248 · see citing works

Reduced-intensity versus conventional myeloablative conditioning allogeneic stem cell transplantation for patients with acute lymphoblastic leukemia: a retrospective study from the European Group for Blood and Marrow Transplantation

Mohty, M., Labopin, M., Volin, L., Gratwohl, A. A., Socié, G., Esteve, J., Tabrizi, R., Nagler, A., Rocha, V., & on behalf of the Acute Leukemia Working Party of, E. B. M. T. (2010) · Blood · doi:10.1182/blood-2010-02-266551 · Cited by 246 · see citing works

Lisocabtagene maraleucel as second-line therapy in adults with relapsed or refractory large B-cell lymphoma who were not intended for haematopoietic stem cell transplantation (PILOT): an open-label, phase 2 study

Sehgal, A. R., Hoda, D., Riedell, P. A., Ghosh, N., Hamadani, M., Hildebrandt, G. C., Godwin, J. E., Reagan, P. M., Wagner‐Johnston, N. D., Essell, J. H., et al. (2022) · The Lancet Oncology · doi:10.1016/s1470-2045(22)00339-4 · Cited by 245 · see citing works

Risk stratification based on both disease status and extra-hematologic comorbidities in patients with myelodysplastic syndrome

Porta, M. G. D., Malcovati, L., Strupp, C., Ambaglio, I., Kuendgen, A., Zipperer, E., Travaglino, E., Invernizzi, R., Pascutto, C., Lazzarino, M., et al. (2010) · Haematologica · doi:10.3324/haematol.2010.033506 · Cited by 243 · see citing works

Outcomes of Nonmyeloablative HLA-Haploidentical Blood or Marrow Transplantation With High-Dose Post-Transplantation Cyclophosphamide in Older Adults

Kasamon, Y. L., Bolaños‐Meade, J., Prince, G. T., Tsai, H., McCurdy, S. R., Kanakry, J. A., Rosner, G. L., Brodsky, R. A., Perica, K., Smith, B. D., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.60.4777 · Cited by 239 · see citing works

Myeloablative vs nonmyeloablative allogeneic transplantation for patients with myelodysplastic syndrome or acute myelogenous leukemia with multilineage dysplasia: a retrospective analysis

Scott, B. L., Sandmaier, B. M., Storer, B. E., Maris, M. B., Sorror, M. L., Maloney, D. G., Chauncey, T. R., Storb, R. F., & Deeg, H. J. (2005) · Leukemia · doi:10.1038/sj.leu.2404010 · Cited by 235 · see citing works

Effect of Inpatient Palliative Care During Hematopoietic Stem-Cell Transplant on Psychological Distress 6 Months After Transplant: Results of a Randomized Clinical Trial

El-Jawahri, A. R., Traeger, L. N., Greer, J. A., Vandusen, H. B., Fishman, S. R., LeBlanc, T. W., Pirl, W. F., Jackson, V. A., Telles, J., Rhodes, A., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.73.2800 · Cited by 234 · see citing works

A multicenter phase II trial of decitabine as first-line treatment for older patients with acute myeloid leukemia judged unfit for induction chemotherapy

Lübbert, M., Rüter, B. H., Claus, R., Schmoor, C., Schmid, M., Germing, U., Kuendgen, A., Rethwisch, V., Ganser, A., Platzbecker, U., et al. (2011) · Haematologica · doi:10.3324/haematol.2011.048231 · Cited by 230 · see citing works

Cotransplantation of Mesenchymal Stem Cells Might Prevent Death from Graft-versus-Host Disease (GVHD) without Abrogating Graft-versus-Tumor Effects after HLA-Mismatched Allogeneic Transplantation following Nonmyeloablative Conditioning

Baron, F., Lechanteur, C., Willems, É., Bruck, F., Baudoux, É., Seidel, L., Vanbellinghen, J.-F., Hafraoui, K., Lejeune, M., Gothot, A., et al. (2010) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2010.01.011 · Cited by 229 · see citing works

A phase 3 randomized study of 5-azacitidine maintenance vs observation after transplant in high-risk AML and MDS patients

Oran, B., Lima, M. J. G. D., Garcia‐Manero, G., Thall, P. F., Lin, R., Popat, U., Alousi, A. M., Hosing, C. M., Giralt, S. A., Rondón, G., et al. (2020) · Blood Advances · doi:10.1182/bloodadvances.2020002544 · Cited by 222 · see citing works

Similar Transplantation Outcomes for Acute Myeloid Leukemia and Myelodysplastic Syndrome Patients with Haploidentical versus 10/10 Human Leukocyte Antigen–Matched Unrelated and Related Donors

Stasi, A. D., Milton, D. R., Poon, L. M., Hamdi, A., Rondón, G., Chen, J. J., Pingali, S. R., Konopleva, M. Y., Kongtim, P., Alousi, A. M., et al. (2014) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2014.08.013 · Cited by 219 · see citing works

Prospective Validation of the Predictive Power of the Hematopoietic Cell Transplantation Comorbidity Index: A Center for International Blood and Marrow Transplant Research Study

Sorror, M. L., Logan, B. R., Zhu, X., Rizzo, J. D., Cooke, K. R., McCarthy, P. L., Ho, V. T., Horowitz, M. M., & Pasquini, M. C. (2015) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2015.04.004 · Cited by 218 · see citing works

How I assess comorbidities before hematopoietic cell transplantation

Sorror, M. L. (2013) · Blood · doi:10.1182/blood-2012-09-455063 · Cited by 218 · see citing works

Quality of life and mood of patients and family caregivers during hospitalization for hematopoietic stem cell transplantation

El‐Jawahri, A. R., Traeger, L. N., Kuzmuk, K., Eusebio, J. R., Vandusen, H. B., Shin, J. A., Keenan, T., Gallagher, E. R., Greer, J. A., Pirl, W. F., et al. (2015) · Cancer · doi:10.1002/cncr.29149 · Cited by 218 · see citing works

Comparison of minimal residual disease as outcome predictor for AML patients in first complete remission undergoing myeloablative or nonmyeloablative allogeneic hematopoietic cell transplantation

Walter, R. B., Gyurkocza, B., Storer, B. E., Godwin, C. D., Pagel, J. M., Buckley, S. A., Sorror, M. L., Wood, B. L., Storb, R. F., Appelbaum, F. R., et al. (2014) · Leukemia · doi:10.1038/leu.2014.173 · Cited by 217 · see citing works

Parameters detected by geriatric and quality of life assessment in 195 older patients with myelodysplastic syndromes and acute myeloid leukemia are highly predictive for outcome

Deschler-Baier, B., Ihorst, G., Platzbecker, U., Germing, U., März, E., de Figuerido, M., Fritzsche, K., Haas, P. S., Salih, H. R., Giagounidis, A. A. N., et al. (2012) · Haematologica · doi:10.3324/haematol.2012.067892 · Cited by 214 · see citing works

Graft-Versus-Host Disease and Graft-Versus-Tumor Effects After Allogeneic Hematopoietic Cell Transplantation

Storb, R. F., Gyurkocza, B., Storer, B. E., Sorror, M. L., Blume, K. G., Niederwieser, D. W., Chauncey, T. R., Pulsipher, M. A., Petersen, F. B., Sahebi, F., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.45.0247 · Cited by 213 · see citing works

Frailty and the management of hematologic malignancies

Abel, G. A., & Klepin, H. D. (2017) · Blood · doi:10.1182/blood-2017-09-746420 · Cited by 212 · see citing works

Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation in Patients With Acute Myeloid Leukemia

Gyurkocza, B., Storb, R. F., Storer, B. E., Chauncey, T. R., Lange, T., Shizuru, J. A., Langston, A. A., Pulsipher, M. A., Bredeson, C., Maziarz, R. T., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.1460 · Cited by 210 · see citing works

Hematopoietic stem cell transplantation-50 years of evolution and future perspectives

Henig, I., & Zuckerman, T. (2014) · Rambam Maimonides Medical Journal · doi:10.5041/rmmj.10162 · Cited by 209 · see citing works

Hematopoietic stem cell transplantation using single UM171-expanded cord blood: a single-arm, phase 1–2 safety and feasibility study

Cohen, S., Roy, J., Lachance, S., Delisle, J., Marinier, A., Busque, L., Roy, D., Barabé, F., Ahmad, I., Bambace, N. M., et al. (2019) · The Lancet Haematology · doi:10.1016/s2352-3026(19)30202-9 · Cited by 209 · see citing works

Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patients

Spyridonidis, A., Labopin, M., Savani, B. N., Niittyvuopio, R., Blaise, D., Craddock, C., Socié, G., Platzbecker, U., Beelen, D. W., Milpied, N. J., et al. (2020) · Bone Marrow Transplantation · doi:10.1038/s41409-020-0803-y · Cited by 209 · see citing works

Single-agent GVHD prophylaxis with posttransplantation cyclophosphamide after myeloablative, HLA-matched BMT for AML, ALL, and MDS

Kanakry, C. G., Tsai, H., Bolaños‐Meade, J., Smith, B. D., Gojo, I., Kanakry, J. A., Kasamon, Y. L., Gladstone, D. E., Matsui, W. H., Borrello, I., et al. (2014) · Blood · doi:10.1182/blood-2014-07-587477 · Cited by 204 · see citing works

Reducing the Risk for Transplantation-Related Mortality After Allogeneic Hematopoietic Cell Transplantation: How Much Progress Has Been Made?

Horan, J., Logan, B. R., Agovi, A. M., Lazarus, H. M., Bacigalupo, A. A., Ballen, K. K., Bredeson, C., Carabasi, M. H., Gupta, V. K., Hale, G. A., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.32.5001 · Cited by 203 · see citing works

Managing high-risk CLL during transition to a new treatment era: stem cell transplantation or novel agents?

Dreger, P., Schetelig, J., Andersen, N. S., Corradini, P., van Gelder, M., Gribben, J. G., Kimby, E. K., Michallet, M., Moreno, C., Stilgenbauer, S., et al. (2014) · Blood · doi:10.1182/blood-2014-07-586826 · Cited by 199 · see citing works

A Risk Score for Mortality after Allogeneic Hematopoietic Cell Transplantation

Parimon, T., Au, D. H., Martin, P. J., & Chien, J. W. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-6-200603210-00007 · Cited by 196 · see citing works

Comparable composite endpoints after HLA-matched and HLA-haploidentical transplantation with post-transplantation cyclophosphamide

McCurdy, S. R., Kasamon, Y. L., Kanakry, C. G., Bolaños‐Meade, J., Tsai, H., Showel, M. M., Kanakry, J. A., Symons, H. J., Gojo, I., Smith, B. D., et al. (2016) · Haematologica · doi:10.3324/haematol.2016.144139 · Cited by 193 · see citing works

Outcomes after allogeneic hematopoietic cell transplantation with nonmyeloablative or myeloablative conditioning regimens for treatment of lymphoma and chronic lymphocytic leukemia

Sorror, M. L., Storer, B. E., Maloney, D. G., Sandmaier, B. M., Martin, P. J., & Storb, R. F. (2007) · Blood · doi:10.1182/blood-2007-07-098483 · Cited by 192 · see citing works

Real-World Evidence of Axicabtagene Ciloleucel for the Treatment of Large B Cell Lymphoma in the United States

Jacobson, C. A., Locke, F. L., Ma, L., Asubonteng, J. O., Hu, Z., Siddiqi, T., Ahmed, S., Ghobadi, A., Miklos, D. B., Lin, Y., et al. (2022) · Transplantation and Cellular Therapy · doi:10.1016/j.jtct.2022.05.026 · Cited by 194 · see citing works

How I manage patients with relapsed/refractory diffuse large B cell lymphoma

Gisselbrecht, C., & Neste, É. V. D. (2018) · British Journal of Haematology · doi:10.1111/bjh.15412 · Cited by 188 · see citing works

Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation in Relapsed, Refractory, and Transformed Indolent Non-Hodgkin's Lymphoma

Rezvani, A. R., Storer, B. E., Maris, M. B., Sorror, M. L., Agura, E. D., Maziarz, R. T., Wade, J. C., Chauncey, T. R., Forman, S. J., Lange, T., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.5477 · Cited by 187 · see citing works

Comprehensive clinical-molecular transplant scoring system for myelofibrosis undergoing stem cell transplantation

Gagelmann, N., Ditschkowski, M., Bogdanov, R., Bredin, S., Robin, M., Cassinat, B., Shahswar, R., Thol, F. R., Heuser, M., Socié, G., et al. (2019) · Blood · doi:10.1182/blood-2018-12-890889 · Cited by 189 · see citing works

Impact of Conditioning Regimen Intensity on Outcome of Allogeneic Hematopoietic Cell Transplantation for Advanced Acute Myelogenous Leukemia and Myelodysplastic Syndrome

Alyea, E. P., Kim, H. T., Ho, V. T., Cutler, C. S., DeAngelo, D. J., Stone, R. M., Ritz, J., Antin, J. H., & Soiffer, R. J. (2006) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2006.06.003 · Cited by 186 · see citing works

Hematopoietic Cell Transplantation as Curative Therapy for Idiopathic Myelofibrosis, Advanced Polycythemia Vera, and Essential Thrombocythemia

Kerbauy, D. M. B., Gooley, T. A., Sale, G. E., Flowers, M. E. D., Doney, K., Georges, G. E., Greene, J. E., Linenberger, M. L., Petersdorf, E. W., Sandmaier, B. M., et al. (2007) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2006.11.004 · Cited by 179 · see citing works

Predictive factors for the outcome of allogeneic transplantation in patients with MDS stratified according to the revised IPSS-R

Porta, M. G. D., Alessandrino, E. P., Bacigalupo, A. P., Lint, M. T. V., Malcovati, L., Pascutto, C., Falda, M., Bernardi, M., Onida, F., Guidi, S., et al. (2014) · Blood · doi:10.1182/blood-2013-12-542720 · Cited by 181 · see citing works

Development and Validation of a Novel Acute Myeloid Leukemia–Composite Model to Estimate Risks of Mortality

Sorror, M. L., Storer, B. E., Fathi, A. T., Gerds, A. T., Medeiros, B. C., Shami, P. J., Brunner, A. M., Sekeres, M. A., Mukherjee, S., Peña, E., et al. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2017.2714 · Cited by 178 · see citing works

Consensus-based definition of unfitness to intensive and non-intensive chemotherapy in acute myeloid leukemia: a project of SIE, SIES and GITMO group on a new tool for therapy decision making

Ferrara, F., Barosi, G., Venditti, A., Angelucci, E., Gobbi, M., Pane, F., Tosi, P., Zinzani, P. L., & Tura, S. (2013) · Leukemia · doi:10.1038/leu.2012.303 · Cited by 178 · see citing works

A novel prognostic model in elderly patients with acute myeloid leukemia: results of 909 patients entered into the prospective AML96 trial

Röllig, C., Thiede, C., Gramatzki, M., Aulitzky, W. E., Bodenstein, H., Bornhäuser, M., Platzbecker, U., Stuhlmann, R., Schuler, U. S., Soucek, S., et al. (2010) · Blood · doi:10.1182/blood-2010-01-267302 · Cited by 176 · see citing works

The cumulative burden of double-stranded DNA virus detection after allogeneic HCT is associated with increased mortality

Hill, J. A., Mayer, B. T., Xie, H., Leisenring, W. M., Huang, M.-L. W., Stevens‐Ayers, T., Milano, F., Delaney, C. S., Sorror, M. L., Sandmaier, B. M., et al. (2017) · Blood · doi:10.1182/blood-2016-10-748426 · Cited by 176 · see citing works

Epidemiological, genetic, and clinical characterization by age of newly diagnosed acute myeloid leukemia based on an academic population-based registry study (AMLSG BiO)

German-Austrian AML Study Group (AMLSG), Nagel, G., Weber, D., Fromm, E., Erhardt, S., Lübbert, M., Fiedler, W., Kindler, T., Krauter, J., Brossart, P., et al. (2017) · Annals of Hematology · doi:10.1007/s00277-017-3150-3 · Cited by 177 · see citing works

Myeloablative allogeneic versus autologous stem cell transplantation in adult patients with acute lymphoblastic leukemia in first remission: a prospective sibling donor versus no-donor comparison

Cornelissen, J. J., van der Holt, B., Verhoef, G. E. G., Veer, M. B. V., van Oers, M. H. J., Schouten, H. C., Ossenkoppele, G. J., Sonneveld, P., Maertens, J. A., Kooy, M. V. M., et al. (2008) · Blood · doi:10.1182/blood-2008-07-168625 · Cited by 173 · see citing works

Alemtuzumab with fludarabine and cyclophosphamide reduces chronic graft-versus-host disease after allogeneic stem cell transplantation for acquired aplastic anemia

Marsh, J. C. W., Gupta, V. K., Lim, Z., Ho, A. Y. L., Ireland, R. M., Hayden, J., Potter, V. T., Koh, M., Islam, M. S., Russell, N. H., et al. (2011) · Blood · doi:10.1182/blood-2010-12-327536 · Cited by 170 · see citing works

Comorbidity is an independent predictor of complete remission in elderly patients receiving induction chemotherapy for acute myeloid leukemia

Etienne, A., Esterni, B., Charbonnier, A., Mozziconacci, J., Arnoulet, C., Coso, D., Puig, B., Gastaut, J., Maraninchi, D., & Vey, N. (2007) · Cancer · doi:10.1002/cncr.22537 · Cited by 170 · see citing works

Cell-based therapeutic strategies for multiple sclerosis

Scolding, N. J., Pasquini, M. C., Reingold, S. C., Cohen, J. A., Sclerosis:, I. C. O. C.-B. T. F. M., Atkins, H. L., Banwell, B., Bar‐Or, A., Bebo, B. F., Bowen, J. D., et al. (2017) · Brain · doi:10.1093/brain/awx154 · Cited by 170 · see citing works

Severe Cytokine-Release Syndrome after T Cell–Replete Peripheral Blood Haploidentical Donor Transplantation Is Associated with Poor Survival and Anti–IL-6 Therapy Is Safe and Well Tolerated

Abboud, R., Keller, J., Slade, M., DiPersio, J. F., Westervelt, P., Rettig, M. P., Meier, S., Fehniger, T. A., Abboud, C. N., Uy, G. L., et al. (2016) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2016.06.010 · Cited by 169 · see citing works

Donor Clonal Hematopoiesis and Recipient Outcomes After Transplantation

Gibson, C. J., Kim, H. T., Zhao, L., Murdock, H. M., Hambley, B., Ogata, A., Madero-Marroquin, R., Wang, S., Green, L., Fleharty, M., et al. (2022) · Journal of Clinical Oncology · doi:10.1200/jco.21.02286 · Cited by 168 · see citing works

Reduced-intensity conditioning with combined haploidentical and cord blood transplantation results in rapid engraftment, low GVHD, and durable remissions

Liu, H., Rich, E. S., Godley, L. A., Odenike, O. M., Joseph, L. J., Marino, S. R., Kline, J. P., Nguyen, V. H., Cunningham, J. M., Larson, R. A., et al. (2011) · Blood · doi:10.1182/blood-2011-08-372508 · Cited by 167 · see citing works

Prognostic impact of pre-transplantation transfusion history and secondary iron overload in patients with myelodysplastic syndrome undergoing allogeneic stem cell transplantation: a GITMO study

Alessandrino, E. P., Porta, M. G. D., Bacigalupo, A. P., Malcovati, L., Angelucci, E., Lint, M. T. V., Falda, M., Onida, F., Bernardi, M., Guidi, S., et al. (2009) · Haematologica · doi:10.3324/haematol.2009.011429 · Cited by 166 · see citing works

Prediction of Allogeneic Hematopoietic Stem-Cell Transplantation Mortality 100 Days After Transplantation Using a Machine Learning Algorithm: A European Group for Blood and Marrow Transplantation Acute Leukemia Working Party Retrospective Data Mining Study

Shouval, R., Labopin, M., Bondi, O., Mishan‐Shamay, H., Shimoni, A., Ciceri, F., Esteve, J., Giebel, S., Gorin, N. C., Schmid, C., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.1339 · Cited by 166 · see citing works

Modified Charlson Comorbidity Index for predicting survival after liver transplantation

Volk, M. L., Hernandez, J. C., Lok, A. S.-F., & Marrero, J. A. (2007) · Liver Transplantation · doi:10.1002/lt.21172 · Cited by 157 · see citing works

A General Practitioner’s Guide to Hematopoietic Stem-cell Transplantation

Bazinet, A., & Popradi, G. (2019) · Current Oncology · doi:10.3747/co.26.5033 · Cited by 157 · see citing works

Bone Marrow Compared with Peripheral Blood Stem Cells for Haploidentical Transplantation with a Nonmyeloablative Conditioning Regimen and Post-transplantation Cyclophosphamide

Castagna, L., Crocchiolo, R., Fürst, S., Bramanti, S., Cheikh, J. E., Sarina, B., Granata, A., Mauro, E., Faucher, C., Mohty, B., et al. (2014) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2014.02.001 · Cited by 155 · see citing works

Prediction of Ischemic Heart Disease and Stroke in Survivors of Childhood Cancer

Chow, E. J., Chen, Y., Hudson, M. M., Feijen, E. A. M., Kremer, L. C. M., Border, W. L., Green, D. M., Meacham, L. R., Mulrooney, D. A., Ness, K. K., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.74.8673 · Cited by 154 · see citing works

TRANSPLANTATION Hematopoietic cell transplantation (HCT)–specific comorbidity index: a new tool for risk assessment before allogeneic HCT

Sorror, M. L., Maris, M. B., Storb, R. F., Baron, F., S, B. M., Maloney, D. G., & Storer, B. E. (2016)

Assignment of scores for the hematopoietic cell transplantation comorbidity index: integer vs exact weights

Sorror, M. L., Storer, B. E., & Storb, R. F. (2010) · Bone Marrow Transplantation · doi:10.1038/bmt.2010.131 · Cited by 9 · see citing works

54: Hematopoietic cell transplantation-comorbidity index (HCT-CI)

Kassar, M., Shell, K., Gregory, S. A., Venugopal, P., Shammo, J. M., & Fung, H. C. H. (2007) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2006.12.057

Hematopoietic Cell Transplantation-Specific Comorbidity Index To Predict Non-Relapse Mortality and Survival after Allografting.

Kato, R., Fukuda, T., Usui, E., Yamasaki, S., Maruyama, D., Morita, Y., Kim, S., Mori, S., Tanosaki, R., Tajima, K., et al. (2005) · Blood · doi:10.1182/blood.v106.11.2731.2731 · Cited by 1 · see citing works

Prospective Validation of the Predictive Power of the Hematopoietic Cell Transplantation Comorbidity Index: A Center for International Blood and Marrow Transplant Research Study

Sorror, M. L., Logan, B. R., Zhu, X., Rizzo, J. D., Cooke, K. R., McCarthy, P. L., Ho, V. T., Horowitz, M. M., & Pasquini, M. C. (2015) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2015.04.004 · Cited by 218 · see citing works